EP3283080
Samsetningar til að stilla C9ORF72 tjáningu
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.4.2016EP published:
18.3.2020EP application number:
16780833.6
EP translation filed:
16.4.2020Grant published:
15.5.2020EPO information:
European Patent Register
Max expiry date:
14.4.2036Expiry date:
14.4.2023
Title:
COMPOSITIONS FOR MODULATING C9ORF72 EXPRESSION
Timeline
Today
15.4.2016EP application
18.3.2020EP Publication
16.4.2020Translation submitted
15.5.2020Registration published
14.4.2023Expires
Owner
Name:
Ionis Pharmaceuticals, Inc.Address:
2855 Gazelle Court, Carlsbad, CA 92010, US
Inventor
Name:
RIGO, FrankAddress:
Carlsbad, CA 92010, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201562148691 PDate:
16.4.2015Country:
US
Number:
201562232941 PDate:
25.9.2015Country:
US
Number:
201562239400 PDate:
9.10.2015Country:
US
Classification
Categories:
C12N 15/113, A61K 31/7125, C07H 21/02
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 5.6.2020
Expires: 14.4.2021
Payer: Árnason Faktor ehf.
Number: 6
Paid: 10.3.2021
Expires: 14.4.2022
Payer: Árnason Faktor ehf.
Number: 7
Paid: 10.3.2022
Expires: 14.4.2023
Payer: Árnason Faktor ehf.